The Guide Finally Breaks: A Tariff-Built Beat, a Margin-Driven Cut to +1–2% Constant-Currency EPS Growth, and a Stock That Had Already Priced It. Maintaining Hold

Results vs. Consensus

Q3 2026 Scorecard

Year-Over-Year Comparisons

Sequential Trajectory (vs. Q2 2026)

Quality of Beat

Revenue: This is the cleanest part of the print. Reported growth of +5.6% breaks down to +3.1% organic, +1.7 points from acquisitions net of divestitures (the 2025 PBNA beverage additions), and +0.7 points of FX, a much smaller translation tailwind than Q2's +2.2 points. Inside organic, effective net pricing added about 3 points and organic volume about 0.5 point at the revenue level. Unit volume was +3% in beverages and +1% in convenient foods globally, or +4% in convenient foods excluding commodity-oriented South African businesses. The problem is geographic. International organic revenue grew ~8% while North America organic was roughly flat (about −0.3% on the reconciliation dollars). So the beat against the ~$24.95B bar is a real beat, but it is International's beat.

Margins: The reported margin lines look better than the economics. Gross margin rose 85bp to 54.4% and core gross margin about 50bp. Tariffs paid in 2025 ran through cost of sales, so the refunds most likely credited the same line, and $178M is about 70bp of revenue (our inference; the release does not state where the refund landed). On that basis the underlying gross margin was roughly flat. Below the gross line, core SG&A grew 8.0% against 5.6% revenue growth, as A&M grew at a double-digit rate in both U.S. businesses and corporate unallocated expense rose 5%. The result was 35bp of core operating-margin contraction with the refund and roughly 105bp without it. That is the second straight quarter of core operating-margin contraction, after +10bp in Q1 and −40bp in Q2. Management now says North America margin pressure continues into Q4.

EPS: Core EPS of $2.34 (+2%) is the right figure, but ex-refund it was about $2.24, roughly 2% down year over year. FX added about a point (the release puts the translation effect on EPS at one point; core constant-currency EPS +1.5%), net interest expense fell by $22M, core pension income rose by $20M, and the share count fell 0.4%. A higher core tax rate (21.2% vs. 19.4%) offset part of that, as management flagged in July. GAAP EPS of $2.23 (+17%) laps $221M of acquisition-related charges, $100M of impairment and other charges and an $82M LatAm indirect-tax charge in the year-ago operating profit, and it absorbed a $179M pension settlement charge this quarter. Disregard it in favor of the core figures.

Segment Performance

The segment split widened again. International grew faster and earned more on every line. North America grew revenue only through acquisitions, and its profit fell even with a one-time refund in it.

Volume columns use the company's unit measures, which exclude acquisitions and divestitures. PFNA and PBNA organic growth round to zero in the release; the reconciliation dollars put both slightly below zero (PFNA $6,514M vs. $6,526M; PBNA $7,289M vs. $7,312M). Margin changes for PFNA, PBNA and International are management's figures; the rest are our arithmetic on the release's segment table.

North America vs. International

Regional totals are sums of the release's segment figures. In Q3, International produced 44% of revenue and 49% of core segment operating profit. Year to date, management puts it at 41% of revenue and 45% of core segment profit. North America core operating profit fell about 6% even with the tariff refund, which the CFO tied to the beverage business. If most of the $178M sat in PBNA, as that framing suggests, underlying North America profit fell by low double digits.

PFNA (Foods North America): Volume Holds, Economics Break

The segment the original upgrade was built on delivered the volume half of the story and failed the profit half. Organic revenue improved from −2% in Q2 to roughly flat. Effective net pricing narrowed to −1 point from −2, and organic volume contributed +0.5 point. Management says U.S. salty-category volume has grown four quarters in a row and outperformed U.S. food and beverage, and that PFNA gained volume share in potato chips, curls and puffs, and SunChips. Portion-control multipacks (now over $3.5B of annual revenue) and the ~$3B permissible portfolio both grew. But core constant-currency operating profit fell 12%, worse than Q2's −8%, and core operating margin fell 280bp to 21.2%. Management attributed the decline to affordability investments, the lap of a prior-year asset-sale gain, and higher A&M, partly offset by productivity and volume.

"The volume bet that we made in snacks North America, especially with the price reset, we are happy with the turnaround in the volume performance. If you think about last year, that business was low single digit negative volume growth. This year, we are low single digit positive volume growth. That is a major turnaround." — Ramon Laguarta, Chairman & CEO

Assessment: Both halves of this are true, and together they are a problem. The price reset bought share and kept unit volume around flat-to-up, so the strategy did what it was designed to do on the volume line. It did not convert into profit: PFNA's operating profit is down 8% year to date, and the margin fell 280bp this quarter, a steeper decline than Q2's roughly 150bp. The company is now raising prices on brands including Doritos, which it cut before the Super Bowl, which makes the affordability program look like a margin donation that is being partly reversed. The asset-sale lap flatters the decline a little, but management did not size it. PFNA is no longer a volume problem. It is a profitability problem, and that is harder to fix with promotions.

PBNA (Beverages North America): The Soft-Drink Problem Goes on the Record

PBNA reported +5% revenue to $7,706M, but acquisitions supplied 6 points, so organic revenue was roughly flat (down from +1% in Q2). Organic volume subtracted about 3 points at the revenue level and pricing added about 3. Unit volume of −2% was better than Q2's −4%, and management said organic volume trends improved sequentially on functional hydration (Gatorade, Propel) and flavored and zero-sugar soft drinks. The Celsius partnership holds nearly 20% of the energy category. Core constant-currency operating profit rose 4% and margin slipped only 15bp, but the tariff refund cushioned both. The CFO said the PBNA tariff benefit "goes away" after Q3, which adds underlying pressure.

"We do not feel good about the beverage business. I think the beverage business, as we put in our remarks, we are competing well in some platforms like hydration, like energy. We are not competing well in soft drinks, so we are putting all the urgency of the business and the focus in improving our performance in soft drinks." — Ramon Laguarta, Chairman & CEO

Assessment: This is the most important new admission of the call. Earlier in this coverage PBNA was the turn that came first, and one quarter ago its margin weakness was explained as Alani mix and a soft convenience-and-gas channel. Now management says it trails the soft-drink category against competitors who "increased their investment in the portfolio, and it is working." That is a competitive diagnosis, not a macro one. The fix is more brand spending and better bottler execution, which takes time and costs margin, and the segment loses the refund tailwind in Q4. PBNA's printed profit growth this quarter overstates its health.

International: The Engine Keeps Accelerating

International organic revenue growth accelerated to 8%, the highest since Q1 2024 and the 22nd consecutive quarter of at least mid-single-digit growth. Core operating profit rose 16% and margin expanded 105bp. Every segment contributed. EMEA grew +9% organic on +7 points of pricing with core c.c. operating profit +19%. Asia Pacific Foods grew volume 11% and organic revenue 9%. IB Franchise grew +7% organic on +5% volume, and LatAm Foods grew +6% organic with +3% volume, and FX translation added 8 points to its reported growth of +14%. Management credited the World Cup activations, Lay's restages, and an expanded bottling relationship with Carlsberg.

"I think it is much more structural. I think we are becoming much more competitive in both foods and beverages in more markets. The scale of the business now is to the point that we put on the remarks that is year-to-date, international is already 45% of our profit, so that we keep building it." — Ramon Laguarta, Chairman & CEO

Assessment: International is the best asset in the case and it got stronger, so the downside floor in our thesis is better supported than it was in July. Two cautions apply. First, EMEA's growth leaned heavily on pricing (+7 points against +1 point of volume), and management flagged rising input costs there in July. Second, a World Cup quarter is a tough comparison for Q3 2027. International can carry the consolidated top line. It cannot carry consolidated earnings while North America profit is falling double digits on an underlying basis, and that is what the guide cut admits.

Key Topics & Management Commentary

Overall Management Tone: The most candid call of the coverage arc. In July management defended the plan and blamed gas prices. In Q3 it conceded that North America "performed below our expectations," that the turn "is taking more time than we planned," and that the company is losing in soft drinks, and it did not mention gas prices once. The confidence was again reserved for International and the top line. On margins and 2027 the answers were directional, not numerical, and the levers named (cost cuts, pricing, refranchising) were broad but unsized.

1. The Guide Cut: Margin, Not Top Line

Management cut FY2026 core constant-currency EPS growth to +1–2% from "the low end" of +4–6%, and core EPS growth to +2.5–3.5% from the low end of +5–7%. At the same time it narrowed organic revenue to ~+3% and raised net revenue to ~+6% on more FX and M&A. The CFO was explicit that the change is margin. Input costs are trending higher, mix is a headwind, and the company chose to keep investing rather than protect the year.

"In North America, we remain committed to improving growth and core operating margin. However, it is taking more time than we planned. Therefore, we expect North America's core operating margin performance to remain under pressure in the fourth quarter." — Steve Schmitt, CFO (prepared remarks)

The headline understates the operating cut. The core tax rate guide also fell to ~21% from ~22%, which adds about 1.3% to EPS on its own. So the operating reduction behind the 2.5-to-3-point cut in core constant-currency EPS growth is closer to 4 points. With year-to-date core EPS at $6.15, the new range implies Q4 core EPS of about $2.19–2.27 against $2.26 a year ago, from about 3% down to roughly flat. The old low end implied about $2.40.

Assessment: This is July's no-reset commitment breaking within one quarter. Management frames it as a choice to sustain investment, and that is partly true. But the July plan already assumed productivity plus the tariff refund would fund both inflation and investment, and it did not. A Q4 reset of this size, driven by input costs that management says "continue to ramp up," almost always reaches into the next year. We treat this as the first cut, not necessarily the last.

2. The Tariff Refund: $178M, 4 Points of the 3%

The release puts the tariff-refund benefit at 4 points of core operating-profit growth, and the prepared remarks size it at $178M. Without it, core operating profit would have fallen about 1% and core operating margin about 105bp. Management flagged the refund in July as about one point of full-year EPS, and it landed as guided. The issue is that it was the difference between a profit decline and a profit increase.

"The piece on margin that is important to model is we did have a benefit in our beverage North America business in the third quarter related to tariffs. We talked a little bit about in our remarks about how much that was, and once that goes away, that puts some more underlying pressure on the North America beverages business that we did not have in the third quarter." — Steve Schmitt, CFO

Assessment: Investors should read Q3 profit as about −1%, not +3%. The refund also distorts the segment picture: PBNA's +4% profit growth and its modest 15bp margin decline would both look much worse without it. Q4 and every quarter of 2027 lose this support, so the earnings base the market will capitalize is lower than Q3's printed $2.34.

3. Organic Growth Crosses 3%, With Pricing Doing More of the Work

The good news is real. Organic revenue of +3.1% is the fastest since Q4 2023, with global beverage organic volume +3% and global convenient-foods volume +1%, or +4% excluding commodity-oriented businesses in South Africa. Management guided to further sequential improvement in Q4 and into 2027 and said it took no resources away from the business to protect Q4.

"If you think about the enterprise, we grew 3.1% in organic net revenue in Q3. That is the fastest rate of growth since Q4 2023. Clearly, an important milestone for us to cross the 3%. We like the way that growth came, which was volume led." — Ramon Laguarta, Chairman & CEO

Assessment: Management calls the growth volume-led, and unit volume did grow in both categories. But at the revenue level, organic volume contributed +0.5 point against +1 point in Q2, so the step-up from +2.4% came from pricing (+3 points, from +2). A 3% top line is still the best since Q4 2023, and the full-year revenue guide moved up (net revenue ~+6%, organic narrowed to ~+3%) as profit guidance moved down. That mix is the core tension of the stock. Revenue is healing through International, while North America margins absorb the cost of holding volume. Revenue growth that does not reach profit does not support the multiple.

4. International: 45% of Profit and Climbing

International delivered +8% organic, +16% core operating profit, and +105bp of margin. Management called it structural rather than a weather-and-World-Cup quarter, citing share held or gained in savory snacks across 11 markets and in beverages across 14 markets year to date.

"Year-to-date, the international business has comprised 41 percent of PepsiCo's net revenue and 45 percent of PepsiCo's core segment operating profit." — Ramon Laguarta, Chairman & CEO (prepared remarks)

Assessment: At 45% of segment profit and growing mid-teens, International is now big enough that a separate valuation of the two halves is a serious question, and an analyst asked it directly (see Q&A). For our thesis, International is the reason the downside is limited. It is not enough, though, to offset a North America profit decline of this size at the consolidated EPS line.

5. Frito-Lay: Share Gains Bought, Margin Paid

PFNA delivered the share and volume outcomes the affordability program targeted and paid for them with a 280bp margin decline. Management's response is portfolio evolution (protein, fiber, simpler ingredients, avocado and olive oils), more away-from-home occasions, and continued multipack expansion, rather than SKU cuts or large M&A.

"We don't expect the consumer to suddenly become in a much better place in the next 12, 18 months. So value, affordability, price points, giving the people the right format." — Ramon Laguarta, Chairman & CEO

Assessment: This 12-to-18-month consumer view is a notable change from July's gas-price explanation, which implied a cyclical recovery. Management now plans for a challenged U.S. consumer through 2027, at the same time as it raises prices to cover input costs. That combination limits how much PFNA margin can recover next year. We expect PFNA profit to stay under pressure into H1 2027.

6. Soft Drinks: "Not Competing Well"

For the first time, management named carbonated soft drinks as a competitive failure. Its plan is more investment behind Pepsi, Mountain Dew and poppi, plus a push to "raise the bar on execution" with bottling partners. Hydration and energy remain the bright spots.

"In soft drinks, as you said, we are dissatisfied. I think there is two things that we are trying to do. One is increase the investment behind the brands. So invest more behind Poppi, Pepsi, Mountain Dew, and some of the other brands we have in soft drinks. The second one is improve the execution." — Ramon Laguarta, Chairman & CEO

Assessment: Losing in a "resilient and profitable" category, in management's own words, while a competitor out-invests you is a structural problem. It adds a second North America pillar under pressure. In July the question was whether Frito-Lay could recover. Now both North America businesses need repair at once, and the remedy for both is more spending.

7. Input-Cost Inflation as Hedges Roll Off

The cost side changed between July and October. Management says its 6-to-12-month hedges shielded the P&L until now, but those hedges are rolling off as energy and agricultural costs rise. It did not size the increase, and it pointed to February for the full view.

"One, I would talk about on cost inflation overall, the teams internally have done a really nice job with our hedging programs. They are typically 6-12 months, and it has shielded us from some costs up until this point where we are starting to see these hedges roll off and essentially our input cost starting to ramp." — Steve Schmitt, CFO

Assessment: The hedge timing is what makes the 2027 risk concrete. If the hedge book covered 6 to 12 months and costs are only now coming through, a large part of the higher input cost lands in H1 2027. That is in addition to the loss of the refund and continued A&M growth. That is why we lower our 2027 view below the pre-print consensus (see Model Update).

8. Pricing Reverses Direction

After a year of affordability cuts, PepsiCo said on the print day that it will raise prices in the single-digit range on Doritos, Ruffles, SunChips and some sodas, with prices still below their levels at the start of the year. On the call, management described a mix of net revenue management tactics (price, pack and mix) plus productivity. It also described guardrails to keep next year's prices affordable.

"That gives us, I think, flexibility in what do we do, to absorb this new wave of inflation that is coming to every country, not only the U.S., given energy prices and given agricultural prices. We're going to see a mix of net revenue management tactics that will impact some pricing, but also mix and all the decisions that we can make around that." — Ramon Laguarta, Chairman & CEO

Assessment: Management frames the pricing as flexibility the volume gains earned, and that is fair. But it also tests whether the share gains survive higher prices. The volume gains came from lower price points, so higher prices put them at risk again. The guardrail limits how much margin pricing can recover. Investors should expect PFNA volume to soften in H1 2027 as these increases reach the shelf.

9. Structural Cost Reduction and "Urgency"

The release and prepared remarks introduce new structural cost actions on top of the existing productivity program, aimed at corporate costs, redundancies and discretionary spending "not directly tied to growth," starting "in the coming months." The CFO said benefits should begin as the calendar turns.

"I would say urgency means we are going to look at every cost with aggressive lenses and with the lenses that everything that is not related to growth will not be part of the company." — Ramon Laguarta, Chairman & CEO

Assessment: This is the right lever, and it is the main offset to the 2027 cost pressure. But it is unsized, and corporate unallocated expense rose 5% this quarter, so the cuts have not started. We give credit for the intent and will model the benefit only when management sizes it, most likely in February.

10. A&M Step-Up and the Media Partnership

A&M grew at a double-digit rate in both U.S. businesses in Q3, and management committed to keep increasing it. It also cited a new global media partnership with Publicis, intended to lower media cost and raise the return on marketing through better data.

"That's why we continue to invest in the business, double-digit A&M in both businesses in the U.S. this quarter. We continue to invest in A&M going forward." — Ramon Laguarta, Chairman & CEO

Assessment: Sustained brand investment is the correct long-term call for soft drinks especially, and we would rather see it than an EPS defense through cuts. But it removes the upside lever for 2027 margins. The media partnership is a plausible efficiency source, but "better return on marketing investment" will take several quarters to show up.

11. Strategic Options: Refranchising and "Every Option"

The most consequential new language came in Q&A. Asked about splitting North America from International, separating snacks and beverages, brand sales and refranchising, the CEO said the company is open to revisiting every option, framed around go-to-market and the business model, and added "we're looking at everything." He named faster refranchising in parts of the U.S. as an active consideration, and said the food-and-beverage integration pilot ("One North America") is working on warehouses and transport, with an investor update planned for "a future meeting."

"The solution will be a mix of solutions for different parts of the country. The key point being growth, marketplace execution, competitive performance, and margin. We'll get to that when the moment comes." — Ramon Laguarta, Chairman & CEO

Assessment: This is the first time in our coverage that management has spoken this openly about structural change. Refranchising parts of the U.S. bottling system was central to the activist case a year ago, and the CEO now presents it as his own option. A hybrid model (integration in some regions, refranchising in others) is a credible path to better margin and capital intensity. But there is no timeline, no sizing and no commitment, and "when the moment comes" is not a date. We count it as real optionality, which supports Hold over Underperform, and not yet as a catalyst.

12. 2027: Nothing Until February

Management declined to give even a partial 2027 view and deferred everything to the Q4 report in February. The priorities it named were faster and more efficient growth in North America, continued investment in International, and discipline on costs and capital.

"We're just not in a position today to provide a complete view of what our expectations might be, and I'd rather not give a partial view now. We'll give more detail on our 2027 expectations in February when we report the fourth quarter." — Steve Schmitt, CFO

Assessment: The silence is reasonable for a company mid-plan, but it leaves the market to model 2027 with three known headwinds (refund lap, input-cost ramp, A&M growth) and two unsized offsets (structural cost cuts, pricing). Published FY2027 consensus figures ran from about $8.95 before the print to about $8.71 after it, with most estimates cut, which is still 4% to 7% above the new FY2026 midpoint. That still looks too high to us, and estimate cuts are likely to continue into February.

Guidance & Outlook

The new guide moves revenue up and earnings down, and the gap between the two is North America margin. Organic growth was narrowed to ~3% with a sequential acceleration expected in Q4. Reported revenue rose to ~6% on more FX and M&A, and a lower tax rate adds a point of EPS. Despite all of that, core EPS growth fell by about 2.5 points at the low end. The prepared remarks put the reason plainly: "we expect North America's core operating margin performance to remain under pressure in the fourth quarter," with productivity and cost control offsetting only part of it.

Implied Q4 setup: Year-to-date core EPS is $6.15 (+5%). The new range implies Q4 core EPS of about $2.19–2.27 against $2.26 in the 16-week Q4 2025, so roughly −3% to flat. The prior low end implied about $2.40 (+6%). This is a cut of roughly $0.13–0.21 to a single quarter, which tells you how much North America margin has moved since July.

Street at: FY2026 consensus sat near $8.55 before the print, so the new midpoint of ~$8.38 is about 2% lower. Late-September downgrades had flagged that the old low end was at risk, so part of this was already in estimates and in the price. The bigger adjustment is FY2027, where pre-print consensus near $8.95 implies ~7% growth off the reset base.

Guidance style: Historically conservative-to-realistic, but 2026 is now a year of two qualifications and one cut: "affirmed" in Q1, "towards the low end" in Q2, and reduced in Q3. Management's credibility on North America timing is the weakest it has been in our coverage.

Analyst Q&A Highlights

What Changed in the Q4 Margin Outlook

The opening question went straight to the guide: if the top-line outlook held and the EPS revision is all margin, what changed, and does a large Q4 revision imply more pressure in 2027? The CFO named input costs and mix, and stressed that the company chose to keep investing.

Q: "Steve, if I can just slip in one on the margin side, obviously the earnings revision in Q4 is margin driven with the top-line expectations holding. Just help us understand what changed there. But I think really the context is when you have a big Q4 revision, it may imply further pressure in 2027."
— Dara Mohsenian, Morgan Stanley

A: "The largest changes, and you mentioned, we said in our prepared remarks, was margin performance is below where we expected it to be. Input costs are trending higher, and mix has been a headwind in particular. But despite these pressures, I think it's important to note that we've decided to sustain key investments around the company to make sure that we stimulate growth and build momentum."
— Steve Schmitt, CFO

Assessment: The answer confirmed the cut is margin-driven and partly a choice, and it did not dispute the 2027 implication. "Margin performance is below where we expected it to be" is a plain admission that the July plan was wrong on cost. Framing the rest as a decision to invest is fair, but it also means the investment will continue into 2027 alongside the higher input costs.

How Much of the Pressure Is Investment vs. Inflation

A follow-up pressed for the split between self-inflicted investment and external inflation, which determines how much of the cut management controls. The CFO declined to quantify it, and pointed to the hedge roll-off and the end of the PBNA tariff benefit.

Q: "I just wanted to ask again, maybe a little bit differently, if you can try to clarify how much of the margin pressure is incremental investment versus incremental and unexpected inflation. Because I think that is really important to just understand both what you are doing versus what you are dealing with from an external environment standpoint."
— Lauren Lieberman, Barclays

A: "I will not get into granular detail, but I can give you at least a few things on, I guess, costs, A&M, and tariffs. One, I would talk about on cost inflation overall, the teams internally have done a really nice job with our hedging programs. They are typically 6-12 months, and it has shielded us from some costs up until this point where we are starting to see these hedges roll off and essentially our input cost starting to ramp."
— Steve Schmitt, CFO

Assessment: The refusal to split the two is the most important gap in the call. If most of the cut is investment, management can reverse it. If most is inflation, it carries into 2027 and pricing has to absorb it. The emphasis on hedges rolling off "up until this point" points to inflation as the larger part, and that is the less favorable reading.

The Size of the Inflation Step-Up and What It Means for H1 2027

The final question asked for the order of magnitude of the inflation change and whether investors should model more pressure in H1 2027. The CFO gave a direction but no number.

Q: "Steve, I think just in the context of the Q4 kind of guidance reduction, maybe you can just give us a sense order of magnitude, how much kind of the inflation expectation moved up that drove that? In that context, I know you don't want to get into 2027, and we're all trying to kind of develop a framework to think about it, but just as some of these hedges kind of roll and obviously you're working through the plan, just if we're constructing a narrative for next year, is it very much the case of, hey, maybe expect a bit more of that pressure, at least in the first half of next year?"
— Peter Galbo, Bank of America

A: "Look, the piece that I would assume is commodities are ramping up, right? We'll see some of that in Q4 as the hedges roll off. Our hedging program again, is 6-12 months. We'll give you a more complete view on how that all comes together in February, but as a general trend, commodities continue to ramp up."
— Steve Schmitt, CFO

Assessment: The CFO did not push back on the H1 2027 framing, and "commodities continue to ramp up" effectively confirms it. Combined with the hedge window, this is the strongest evidence on the call that 2027 consensus needs to come down.

Which Way North America Pricing Goes, and What "Urgency" Means

Against conflicting media reports on snack pricing, an analyst asked for the direction of travel on North America foods pricing and what "urgency" means in practice for beverages. The CEO described urgency as aggressive cost scrutiny and higher execution standards, and confirmed that pricing will rise through a mix of tactics to absorb inflation.

Q: "I know there has been many questions around this topic, but just to make sure that we understand specifically, particularly because of various media reports of higher pricing or lower pricing or whatever it happens to be, what exactly is the plan? Which direction are you, what is the correct direction of travel? That is on North American foods."
— Kaumil Gajrawala, Jefferies

A: "We were negative low single digit in volume in snacks in the U.S. Now we're positive volume and units and gaining shares. That gives us, I think, flexibility in what do we do, to absorb this new wave of inflation that is coming to every country, not only the U.S., given energy prices and given agricultural prices."
— Ramon Laguarta, Chairman & CEO

Assessment: The answer clarified the direction: prices go up, carefully, after a year of going down. Management presents the volume gains as the reason it can now raise prices. The risk is the reverse: the gains came from lower prices, so higher prices could undo them. The answer did not address that.

Why Soft Drinks Fell Short, and Whether Q4 Organic Improves

An analyst asked why the beverage business has fallen short and what the company will do differently, and whether the ~3% organic guide implies a Q4 acceleration from 3.1%. The CEO confirmed the sequential improvement and named two remedies for soft drinks: more brand investment and better execution.

Q: "Ramon, it's pretty clear that you are not pleased with the performance of the business. But as you take a step back, can you maybe unpack why performance has fallen short of expectations and as you think about the path forward, what you plan to do differently?"
— Peter Grom, UBS

A: "In soft drinks, as you said, we are dissatisfied. I think there is two things that we are trying to do. One is increase the investment behind the brands... The second one is improve the execution. I think there is opportunities for us to become a better, raise the bar on execution in our beverage business, and the team is fully focused. We have great partners in our bottling partners as well, and that is the focus, execution improvements and more investments in the brands to be competitive with our key competitors that have increased their investment in the portfolio, and it is working."
— Ramon Laguarta, Chairman & CEO

Assessment: Management gave the "what" (more investment, better execution) but not the "why." It never explained why the soft-drink business fell behind in the first place beyond competitors spending more. The admission that a competitor's investment "is working" is candid. It also means PepsiCo is the one responding, and responding costs margin.

Portfolio Choices in Frito-Lay: SKU Cuts, Brand Mix and M&A

An analyst asked whether PFNA should accelerate SKU rationalization and move investment to brands with momentum, and whether M&A should supplement growth. The CEO defended the portfolio and described a two-track plan of value and price points for a stretched consumer plus growth platforms.

Q: "Curious if you would consider accelerating SKU rationalization on some of the underperforming brands in that business, thinking about maybe in an attempt to redeploy investments behind SKUs that are actually showing signs of improvement or momentum."
— Bonnie Herzog, Goldman Sachs

A: "Listen, I think the portfolio is in a very good place from where the consumer is today and where the consumer is going tomorrow... Now, we need to put more investment in scaling up those platforms. That's what we're trying to do, taking cost from other parts of the portfolio of the P&L and investing in those growth platforms for the future."
— Ramon Laguarta, Chairman & CEO

Assessment: Management rejected the idea that the portfolio needs pruning and kept M&A to small tuck-ins. The answer is consistent with the strategy, but it puts the full burden of the PFNA recovery on reallocating cost inside the P&L. Given the 280bp margin decline, investors will want to see that reallocation produce profit, not only volume.

Bigger Strategic Change: Splits, Divestitures and Refranchising

The most strategically significant question asked whether the board is considering larger structural moves to unlock value, from separating North America and International to splitting snacks and beverages, brand divestitures or bottler refranchising. The CEO did not rule anything out and singled out faster refranchising.

Q: "Can you comment on the Board's consideration for bigger strategic changes? I think there's an argument to be made that there's real latent value in your stock price. Whether this is splitting North American International, which have very different financial profiles now, splitting snacks and beverages, which you're well aware has been discussed for decades among the investment community, brand divestitures, bottler refranchising."
— Kevin Grundy, BNP Paribas

A: "Listen, obviously, we're not satisfied with the performance, and that means that we have to look at options that improve our performance long term, right? It's not only about the short term, it's the long term. We have been talking about how, especially to your point on go to market and business model, listen, we're open to revisiting every option. We're working with the team on accelerating some of the tactics on the integration part where we can eliminate cost. But also we're looking at, are there opportunities to expand or accelerate some of the refranchising in some parts of the country where we have good partners and where it makes sense that partnership will drive better execution and potentially better margin for the company."
— Ramon Laguarta, Chairman & CEO

Assessment: "Open to revisiting every option" is a new and material statement from a CEO who has long defended the integrated model, even though he framed it around go-to-market and the business model rather than a break-up. Refranchising was named specifically, and that is the most achievable of the options listed. A full separation was neither endorsed nor dismissed. This is the strongest support on the call for a value-unlock case, but without a timeline it remains optionality.

The One North America Integration Pilot and the Hybrid Model

Two analysts asked for an update on the Texas food-and-beverage integration pilot and how to measure the success and timing of a hybrid model that combines integration in some regions with refranchising in others. Management said the physical integration of warehouses and transport works, that it is now testing store delivery, and that it will brief investors at a later date.

Q: "I was wondering if you could give us an update on your efforts to integrate the food and beverage business in the U.S., if you were piloting something in Texas, and I think it's been going on now about eight or nine months, so I'd love to get an update on that."
— Multiple analysts incl. Robert Ottenstein, Evercore ISI; Andrea Teixeira, JPMorgan

A: "On One North America, we keep working, not so much the strategy anymore, but the execution of this tactic. There is a lot of positive news. We will update all the investors in a future meeting... This will apply to some parts of the country, as we said. I think long term, this will apply to some parts of the country. Now, there are other parts of the country where this will not apply, and that is the comment I made earlier about, can we accelerate refranchising in some other parts of the country and take value earlier?"
— Ramon Laguarta, Chairman & CEO

Assessment: The update moved the pilot from "test" to "execution," and linked it to refranchising for the first time as two halves of one regional plan. That is progress. But the July promise of an update "later in the year, early next year" became "a future meeting," with no metrics on savings or service levels. The integration story has been deferred for three quarters running.

What They're NOT Saying

1. The size of the input-cost increase: Asked directly for the order of magnitude, management said only that commodities "continue to ramp up." The largest driver of the guide cut has no number attached, so investors cannot judge how much of it carries into 2027.
2. The split between investment and inflation: The CFO declined to say how much of the margin pressure is chosen A&M and how much is external cost. That split decides whether the 2027 base is a choice or a constraint.
3. Any 2027 framework: Management would not give "a partial view" and deferred everything to February. With published FY2027 consensus figures still between about $8.71 and $8.95, the silence leaves an estimate gap open for four months.
4. Profit ex-refund, by segment: The $178M refund was disclosed in total, and the CFO tied it to the beverage business, but the release does not show PBNA profit without it. The segment's +4% profit growth cannot be read cleanly as a result.
5. The size and timing of structural cost cuts: The new actions are "being identified" and will "take effect in the coming months," with no savings target. Corporate unallocated expense rose 5% in the quarter.
6. The PFNA asset-sale lap: Management cited the lap of a prior-year asset-sale gain as one cause of the 280bp margin decline without sizing it, so the clean PFNA margin trend is unclear.
7. The volume cost of the price increases: The new single-digit increases were announced the same day, but management gave no view on what elasticity it expects. The share gains rested on the lower prices now being partly reversed.
8. Gas prices and the activist: Gas prices were July's main explanation and were not mentioned in the Q3 remarks or Q&A. The activist investor whose stake prompted the refranchising debate was also not mentioned, even as management adopted refranchising as its own idea.

Market Reaction

• Pre-print setup: PEP closed at $123.73 on October 7, the day before the before-the-open print. That was the bottom of its 52-week closing range ($123.73–$170.49). The stock was −13.8% year to date (from $143.52) while the S&P 500 was +14.0%, −10.9% over the trailing twelve months, and −10.6% over the prior 30 days (from $138.45 on September 8). Late September brought a cluster of sell-side downgrades and target cuts on a stalled Frito-Lay recovery and expected Q4 cost pressure.
• Reaction (same-day, BMO): The stock opened at $124.31 (+0.5%), traded between $124.05 and $129.50, and closed at $128.34, up 3.7% (+$4.61), on 24.0M shares versus an 8.8M 30-day average (2.7x volume). The S&P 500 fell 0.5% on the session, so PEP outperformed by about 4 points.
• Follow-through: PEP gave back 1.8% on October 9 to $125.97 as target cuts landed, then recovered to $128.38 by the October 15 close. That is +3.8% from the pre-print close, against −0.7% for the S&P 500 over the same span.

A reset that was sold before it was announced. A 3.7% rally on 2.7x volume, on the day of a meaningful EPS guide cut, only makes sense against the setup. The stock had already fallen 10.6% in a month as the Street downgraded it on exactly this risk, including explicit warnings that Q4 would need heavy cost savings to reach the old low end. By October 7 it traded at about 14.8x the eventual new guidance midpoint, near the bottom of its five-year range, with a 4.8% yield. The cut was about 2% at the EPS midpoint, which is meaningful but not the larger reset some feared. Revenue and EPS both beat, organic growth accelerated, and management opened structural options it had not discussed before. Positioning was braced for bad news, and the print delivered enough relief to cover.

What the follow-through says. The next-day fade and the flat drift afterward fit a clearing event rather than a re-rating. The market accepted the FY2026 reset as priced but did not pay up for the structural-options language or the price increases. That matches our read: the stock now prices a lower 2026, but not yet the 2027 that February has to reveal.

Street Perspective

Debate: Is This the Kitchen-Sink Quarter, or the First of Several Cuts?

Bull view: Management has finally reset to a number it can beat. The FY2026 cut was smaller than feared, the stock had already de-rated to a five-year-low multiple, and the late-September downgrades marked capitulation. With structural cost cuts starting at the turn of the year and price increases rebuilding margin, the earnings trough is Q4 2026, and estimates can stabilize in February.

Bear view: A Q4 cut driven by input costs that are "ramping up" as hedges roll off is the start of the 2027 problem, not the end of the 2026 one. The refund disappears, A&M keeps growing, North America profit is falling double digits on an underlying basis, and FY2027 consensus near $8.95 implies growth the business is not showing. February brings a second reset.

Our take: The bear case is stronger on 2027 numbers and the bull case is stronger on price. We expect FY2027 estimates to fall toward ~$8.60, roughly 3% growth, and we do not think February clears the stock. But at ~15x a reset base with a 4.6% yield, much of a modest 2027 cut is already in the price. Another leg down needs a 2027 framework that implies flat-to-down earnings.

Debate: Does Structural Change Unlock Value?

Bull view: International is now 45% of segment profit, grows mid-teens and expands margin, and it is buried inside a company valued as a struggling U.S. staple. Management's new openness to revisiting "every option" on go-to-market and the business model, starting with faster refranchising of U.S. bottling, could lower capital intensity, lift margins and eventually expose the value of the international business. That is a catalyst the stock has not had before.

Bear view: PepsiCo has talked about integration pilots and hybrid models for a year without a number. Refranchising takes years, carries dis-synergies, and helps margins more than earnings. A full separation would be complex, and management has not endorsed one. "When the moment comes" is not a catalyst.

Our take: This is the most important change in the long-term case this quarter, and it is the main reason we stay at Hold rather than move to Underperform. The bear camp is right that nothing is sized or dated. We will treat refranchising as a catalyst only when management gives a regional scope and a timeline, most likely at the promised investor update.

Debate: Can North America Recover While It Raises Prices?

Bull view: The affordability reset did its job: PFNA gained volume share for several quarters, the U.S. salty category grew volume four quarters running, and household penetration improved. That earned the right to take modest pricing to cover inflation, with prices still below where they started 2026. Meanwhile, more A&M and better execution start to repair soft drinks.

Bear view: PFNA gained share by cutting prices and paid with a 280bp margin decline. Now it raises prices into a consumer management itself expects to stay "challenged" for 12 to 18 months, so the volume can fade while the margin recovers only partly. In beverages, a competitor is out-investing PepsiCo in soft drinks, and catching up costs margin too.

Our take: We side with the bears for H1 2027. Taking price after a price-led share gain usually gives back some of the share, and both North America businesses now need more spending at the same time as input costs rise. We expect a slow, uneven North America margin recovery, more likely in H2 2027 than H1, and we would want to see PFNA hold volume after the increases before turning constructive.

Model Update & Valuation Framework

Valuation framework: At the $128.38 October 15 close, PEP trades at about 15.3x the ~$8.38 midpoint of the reset FY2026 guide and about 14.9x our ~$8.60 FY2027 estimate, with a 4.6% dividend yield on the $5.92 annualized dividend. The payout ratio on FY2026 core EPS is about 71%, so the 54-year dividend record is not at risk, but dividend growth could slow if 2027 earnings stall. Our base-case PT moves to ~$135 from ~$145. That applies ~15.7x to FY2027E core EPS and implies about 5% price upside plus the 4.6% yield, a ~10% total return roughly in line with our 12-month S&P 500 expectation, which is the Hold threshold. The bull case (~$155) needs management to scope and date refranchising and North America margins to turn by mid-2027. The bear case (~$110, −14% before the yield) needs February's framework to show 2027 earnings declining toward ~$8.15 as input costs outrun pricing and cost cuts.

Balance sheet and cash: Year-to-date operating cash flow was $7,950M against $5,468M a year ago, and free cash flow (operating cash flow less capex plus asset-sale proceeds) was $5,857M against $3,241M. Higher net income and better payables timing (a $358M outflow against $1,647M a year ago) drove most of the gain. Net debt was about $40.7B at the quarter end against about $39.7B at year end. The $8.9B cash-return plan is unchanged, and $5,935M of dividends and $739M of buybacks were paid year to date. Cash generation is not the problem in this story.

Revised risk-reward: In July the operating trajectory stalled while the valuation de-rated, which made the case balanced. In October the operating trajectory got worse on profit and better on revenue, the valuation de-rated further before the cut, and a structural-options case appeared. The net is still balanced, but with wider outcomes on both sides. The bear path runs through February's 2027 numbers, and the bull path runs through a future investor meeting. Hold is the honest rating until one of them resolves.

Thesis Scorecard: The Q2 2026 Signposts, Graded

The Q2 2026 note named nine signposts for this quarter and two sets of rating triggers. Q3 missed most of the margin signposts, met the International signpost, and partly met the top-line signposts.

Scorecard summary: Graded against the Q2 note's own "Bearish if" definitions, eight of nine signposts landed bearish, two of them narrowly (PFNA organic revenue at slightly negative after −2%, and Texoma, where the update slipped again but refranchising opened). Only International was bullish. On the Q2 rating triggers: the conditions for a move back to Outperform were not met. Of the Underperform triggers, the guide clause was met (a cut below the +4% floor, driven by inflation outrunning the refund and productivity), and the no-reset clause effectively broke in Q4. The PFNA clause (volume outright negative and organic revenue weaker) was not met, since PFNA organic improved. The Bottom Line explains why we hold the rating despite the guide clause.

Standing Thesis Pillars: Status After Q3 2026

This scorecard follows the five bull and four bear pillars of our standing thesis, which consolidates the wider matrix the Q2 report printed. That matrix already marked the cost program as broken for Q2; the "After Q2" column below shows the consolidated status, and Q3 confirms the break for the full year.

Overall: The thesis weakened on earnings and strengthened on optionality. The productivity pillar, which the Q2 report already showed breaking for that quarter, is now broken for the year, two bear points escalated to materializing, and a new bear point opened on soft drinks. On the other side, International strengthened, the valuation floor held under real pressure, and the structural-options pillar improved for the first time in three quarters. The net is a lower earnings path with a wider range of outcomes.

Action: Hold. Do not add ahead of the February 2027 framework, which is the next decisive event. Holders keep the 4.6% yield and the structural optionality. The rating moves to Underperform if February implies flat-to-down 2027 core EPS, and toward Outperform only with a scoped refranchising plan plus evidence that PFNA keeps its volume after the price increases.

Bottom Line: The Trigger Was Hit, but the Price Got There First

Rating decision: We maintain Hold, with conviction lowered. The coverage arc is now Hold (initiating, Q2 2025), Hold (Q3 2025), Outperform (Q4 2025), Outperform (Q1 2026), Hold (Q2 2026), and Hold (Q3 2026). In July we named a cut below the +4% core constant-currency EPS floor as a path to Underperform. That cut arrived, so the decision to stay at Hold needs a clear explanation:

• The trigger assumed a below-floor cut would hit a stock priced for the low end of the old range. Instead, the stock fell 10.6% in the 30 days before the print, lost two Buy ratings, and closed at a 52-week low of $123.73, within about 3% of our $120 bear case. The price reached the bear scenario before the guide did.
• The cut was about 2% at the EPS midpoint, and the market's response (+3.7% on 2.7x volume, holding most of it a week later) shows it was priced.
• The PFNA half of the trigger did not trip. Frito-Lay organic revenue improved from −2% to roughly flat, and volume did not turn negative.
• The cut is margin-driven by input costs and a decision to keep investing, while the top line accelerated to +3.1% organic. That is a different failure from a demand collapse.
• Management opened structural options, including faster refranchising, that were not on the table in July. That widens the upside range.

We also want to be clear about what got worse. The productivity engine that was supposed to fund the North America investment broke. The tariff refund flattered Q3 by 4 points of profit growth and will not recur. Both North America businesses now need more spending at once, and input costs are rising as hedges roll off into 2027. Management's credibility on North America timing is at a low for our coverage. Those facts keep us from Outperform and move the risk toward a further downgrade.

What would change our mind:

• To Underperform: February's 2027 framework implies flat-to-down core EPS growth, OR the price increases cost PFNA its volume gains (volume turns clearly negative in Q4 or Q1 2027), OR North America margin contraction widens after the refund lap with no sized cost program to offset it.
• Back to Outperform: Management scopes and dates a refranchising or structural plan with a quantified margin or capital benefit, AND PFNA holds flat-to-positive volume through the price increases, AND the 2027 framework shows core EPS growth of mid-single digits supported by sized cost savings.

Signposts for Q4 2026 earnings (February 2027):